Skip to content Skip to footer
Fondaparinux: Benefits, Reviews, Info, Side Effects!
Rx Details
Fondaparinux
Arixtra, Fondaparinux sodium
Fondaparinux
Prescription
Anticoagulant
Drugs
Prescription Only
prevention of deep vein thrombosis, treatment of acute pulmonary embolism, prevention of venous thromboembolism, treatment of acute deep vein thrombosis
Anemia, Bleeding, Dizziness, Elevated Liver Enzymes, Fever, Headache, Hypotension, Injection Site Reactions, Insomnia, Nausea, Rash, Thrombocytopenia
Fondaparinux is an anticoagulant medication used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). The dosage of fondaparinux can vary based on the specific condition being treated and the patient’s weight. Here are some general guidelines: 1. **Prevention of DVT following surgery**: – For patients weighing 50 kg or more: 2.5 mg once daily, starting 6 to 8 hours after surgery. – For patients weighing less than 50 kg: Fondaparinux is not recommended for DVT prophylaxis. 2. **Treatment of DVT and PE**: – For patients weighing less than 50 kg: 5 mg once daily. – For patients weighing 50 to 100 kg: 7.5 mg once daily. – For patients weighing more than 100 kg: 10 mg once daily. These dosages are typically administered via subcutaneous injection. It’s important to follow a healthcare provider’s instructions and consider individual patient factors when determining the appropriate dosage. Always consult with a healthcare professional for specific medical advice and before starting any new medication.
Deep vein thrombosis, pulmonary embolism, venous thromboembolism prevention
Fondaparinux has a favorable safety profile.
No Interactions Reported
$50 – $200
$1,200

A Synopsis of

Fondaparinux

Fondaparinux is a medication that belongs to a class of drugs known as anticoagulants, or blood thinners. It is commonly used to prevent blood clots from forming in patients who are at risk for conditions such as deep vein thrombosis (DVT) or pulmonary embolism. Fondaparinux works by inhibiting the activity of a specific clotting factor in the blood, thereby reducing the risk of clot formation.

It is important to take Fondaparinux exactly as prescribed by your healthcare provider, as the dosage and frequency of administration will vary depending on your individual medical condition and needs. It is typically administered as a subcutaneous injection, and should not be taken orally.

Like all medications, Fondaparinux may cause side effects in some individuals. Common side effects may include bruising or bleeding at the injection site, as well as a decrease in platelet count. In rare cases, more serious side effects such as allergic reactions or severe bleeding may occur. It is important to seek medical attention immediately if you experience any unusual symptoms while taking Fondaparinux.

Before starting Fondaparinux, be sure to inform your healthcare provider about any other medications or supplements you are currently taking, as well as any medical conditions you may have. This will help to ensure that Fondaparinux is safe and appropriate for you to use.

In conclusion, Fondaparinux is a valuable medication for preventing blood clots in high-risk patients. By following your healthcare provider’s instructions and monitoring for any potential side effects, you can safely and effectively benefit from the use of this medication.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN